FDA hits Praxis with 3-month delay for epilepsy drug verdict
The delay is largely “benign” for Praxis Precision Medicines, according to Jefferies, which emphasized that the FDA did not flag safety or manufacturing issues.
FDA hits Praxis with 3-month delay for epilepsy drug verdict Read More »
